Differential Methotrexate Resistance in Childhood T- Versus Common/PreB-Acute Lymphoblastic Leukemia Can Be Measured by an In Situ Thymidylate Synthase Inhibition Assay, But Not by the MTT Assay

This publication has 31 references indexed in Scilit:

• Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 1998
• Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia
  Critical Reviews in Oncology/Hematology, 1997
• Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia.
  Journal of Clinical Investigation, 1994
• Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1993
• Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia
  The Lancet, 1991
• Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay
  The Lancet, 1991
• Deoxycytidine kinase is constitutively expressed in human lymphocytes: Consequences for compartmentation effects, unscheduled dna synthesis, and viral replication in resting cells
  Experimental Cell Research, 1988
• Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia
  Cancer Letters, 1988
• Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum
  The International Journal of Cell Cloning, 1986
• Polyglutamation of methotrexate. Is methotrexate a prodrug?
  Journal of Clinical Investigation, 1985